Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05954728 · ClinicalTrials.gov registry record · NA

Cognitive-behavioral Therapy vs. Nutrition Counseling for Avoidant/Restrictive Food Intake Disorder

A NA study of Avoidant/Restrictive Food Intake Disorder (ARFID), sponsored by Massachusetts General Hospital.

Active
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT05954728 is a NA study of Avoidant/Restrictive Food Intake Disorder (ARFID) that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05954728, a NA study of Avoidant/Restrictive Food Intake Disorder (ARFID), is active but no longer recruiting, sponsored by Massachusetts General Hospital.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This study is a randomized controlledlinical trial, assessing the efficacy of cognitive- behavioral therapy (CBT-AR) and nutrition counseling for avoidant/restrictive food intake disorder (ARFID) for children and adolescents (ages 10-18 years).

Interventions

  • BEHAVIORAL Cognitive-Behavioral Therapy for Avoidant/Restrictive Food Intake Disorder (CBT-AR)
  • BEHAVIORAL Nutrition Counseling for Avoidant/Restrictive Food Intake Disorder

Study Locations (1)

Massachusetts

  • Eating Disorders Clinical and Research Program - Boston

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2024-01-31
Est. Completion 2026-03-31
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT05954728

The ClinicalTrials.gov registry entry for NCT05954728 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Avoidant/Restrictive Food Intake Disorder (ARFID) appearing as the primary indexed condition, and to 2 interventions - of which Cognitive-Behavioral Therapy for Avoidant/Restrictive Food Intake Disorder (CBT-AR) is the first listed.

NCT05954728 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05954728 about?

NCT05954728 is a clinical study titled "Cognitive-behavioral Therapy vs. Nutrition Counseling for Avoidant/Restrictive Food Intake Disorder". This study is a randomized controlledlinical trial, assessing the efficacy of cognitive- behavioral therapy (CBT-AR) and nutrition counseling for avoidant/restrictive food intake disorder (ARFID) for children and adolescents (ages 10-18 years).

What is the current status of trial NCT05954728?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2024-01-31. Estimated completion is 2026-03-31.

What conditions does trial NCT05954728 study?

This clinical trial studies the following conditions: Avoidant/Restrictive Food Intake Disorder (ARFID).

What interventions are being tested in trial NCT05954728?

The interventions under investigation include: Cognitive-Behavioral Therapy for Avoidant/Restrictive Food Intake Disorder (CBT-AR) (BEHAVIORAL), Nutrition Counseling for Avoidant/Restrictive Food Intake Disorder (BEHAVIORAL).

Who is sponsoring clinical trial NCT05954728?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05954728 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.